Inflammation, demyelination, and degeneration - recent insights from MS pathology.
about
Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic painTherapeutic targets in the ASK1-dependent stress signaling pathwaysDrug repurposing: a systematic approach to evaluate candidate oral neuroprotective interventions for secondary progressive multiple sclerosisThe detection of surfactant proteins A, B, C and D in the human brain and their regulation in cerebral infarction, autoimmune conditions and infections of the CNS.Infection risk in patients on multiple sclerosis therapeutics.Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).Primary Progressive Multiple Sclerosis: Putting Together the PuzzleElevated Levels of Proinflammatory Cytokines in Cerebrospinal Fluid of Multiple Sclerosis Patients.Triiodothyronine administration ameliorates the demyelination/remyelination ratio in a non-human primate model of multiple sclerosis by correcting tissue hypothyroidism.Inhibition of SLPI ameliorates disease activity in experimental autoimmune encephalomyelitis.Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 studyα-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejectionNovel Therapeutic Targets in Neuroinflammation and Neuropathic PainMetabolic dysfunctions in multiple sclerosis: implications as to causation, early detection, and treatment, a case control studyPeroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi.Mechanism of experimental autoimmune encephalomyelitis in Lewis rats: recent insights from macrophages.The Lyme disease spirochete Borrelia burgdorferi induces inflammation and apoptosis in cells from dorsal root gangliaCortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple SclerosisGlial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.Immunology and oxidative stress in multiple sclerosis: clinical and basic approach.Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin.Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease durationCurrent understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.No association of AQP4 polymorphisms with neuromyelitis optica and multiple sclerosisNeuropathology of mood disorders: do we see the stigmata of inflammation?The executioners sing a new song: killer caspases activate microglia.Arterial, venous and other vascular risk factors in multiple sclerosis.Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.Relapsing and progressive forms of multiple sclerosis: insights from pathology.The central role of mitochondria in axonal degeneration in multiple sclerosis.Pathological differences between white and grey matter multiple sclerosis lesions.Enhanced Fluorine-19 MRI Sensitivity using a Cryogenic Radiofrequency Probe: Technical Developments and Ex Vivo Demonstration in a Mouse Model of Neuroinflammation.Inherited and acquired disorders of myelin: The underlying myelin pathology.Astrocytes in multiple sclerosis.Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis.SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.Androstenediol Reduces Demyelination-Induced Axonopathy in the Rat Corpus Callosum: Impact on Microglial Polarization.Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.Phagocytosis of neuronal debris by microglia is associated with neuronal damage in multiple sclerosis.
P2860
Q21284848-2913F304-2CD1-4E98-9AEE-6830075E5871Q26999030-6275821B-9788-4315-B98B-D2468630F8C8Q28545984-2A1FB192-C87B-4AF1-8C9D-54D28EFBC560Q30317702-381D5513-EF90-4BF8-8AE8-759FDA9D1D35Q30908652-3AB18AC3-DD30-4AEC-ACA1-9F4EDEEA12BFQ31044261-1739DA14-02ED-4E03-9F72-E4A133B7C558Q33365606-938871E7-E91F-44E8-B9B8-F140A76D56ABQ33700802-C40CDCE0-0815-4355-8696-A297A86708F0Q34195644-5E698039-37BF-4D54-9981-E5FDBC345492Q34204791-B9CB3BD1-FE4E-44B4-8901-9B435C3D7ED7Q34614995-651555AF-0C44-47AD-A9A3-16A33CEA20B0Q35286904-91B74FC8-E1AD-4BF9-AB8B-E7D1F56585A7Q35688300-5CBA14FD-9C0C-4C73-BDCD-65C6C44CE239Q35756786-A54FCF24-8599-4C24-B52B-1B1048C58F24Q36066219-56124788-8324-4B46-A077-13F60804306CQ36156581-1C20FFAA-7DF5-4FE9-8211-580C32292422Q36319914-E24BCA50-F89E-47D8-B95D-6E7518BA3552Q37042125-9F428EE6-78C3-4F20-93AC-F6DBDAB9B9BDQ37172369-D1ADC698-5106-467D-9593-C66D0020DD04Q37220640-C633C802-5FF6-4439-BAAD-E4A7CEEA2446Q37224656-2EB90C47-49DE-410C-9367-63311D6C2824Q37275299-D8F9E8BF-2892-4F34-B7D1-31C7DBAA5D60Q37303007-9CAA9420-B4A1-48E8-A57A-FC505FDFD05EQ37541906-C4BFAF42-E48C-4AA9-AC81-9B2DBB4889FEQ37585443-80A2FFC3-CF3C-4A43-B832-EB6F0F5506B2Q37648274-0E4FA9A1-5D52-4FD2-9812-1E6F0D5E989CQ37916221-6517A502-6ECB-42B9-A07B-1D328A494FE5Q38042766-3AE66461-76F0-4784-B968-8570B71D605DQ38056688-F7739904-1E32-494B-B865-03BDC10CB04CQ38203770-994689B0-446B-4A4B-B8EC-D3A6B49DACF0Q38239792-453240C6-49A4-42D4-A5FA-03F2B63E6210Q38551949-4288CC5E-62E2-40DF-AB84-C060856E6633Q38635918-9436171A-79A7-4FD0-A04A-4141CF05E788Q38805611-EDC72F7B-BCD5-4902-905F-94687CA57AEEQ38840390-58C354CA-4CA6-4095-8F2B-AEBD9FD58A77Q38893637-AAEA9987-CF4F-4A74-B40A-A17C62A34A23Q38913236-28A94CD2-ED3C-46A1-B947-022B297BC7AAQ38915955-81832238-6215-45C3-B132-AB2EFAB4D3A9Q38964016-C7BCF3DD-E5D7-4652-BED4-367EBFF2BA1FQ39429415-C8318BA7-F0BA-4408-AA44-1335D566DD73
P2860
Inflammation, demyelination, and degeneration - recent insights from MS pathology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammation, demyelination, and degeneration - recent insights from MS pathology.
@en
Inflammation, demyelination, and degeneration - recent insights from MS pathology.
@nl
type
label
Inflammation, demyelination, and degeneration - recent insights from MS pathology.
@en
Inflammation, demyelination, and degeneration - recent insights from MS pathology.
@nl
prefLabel
Inflammation, demyelination, and degeneration - recent insights from MS pathology.
@en
Inflammation, demyelination, and degeneration - recent insights from MS pathology.
@nl
P1476
Inflammation, demyelination, and degeneration - recent insights from MS pathology
@en
P2093
Christiane Wegner
Wolfgang Brück
P304
P356
10.1016/J.BBADIS.2010.07.007
P407
P577
2010-07-15T00:00:00Z